Prosight Management, LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 42 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$4,097,000
-23.4%
341,457
-22.1%
2.28%
-41.7%
Q2 2018$5,349,000
+2.3%
438,422
-17.4%
3.92%
+19.6%
Q1 2018$5,229,000
-44.8%
530,848
-21.8%
3.28%
-52.9%
Q4 2017$9,469,000678,7936.96%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders